This inventor holds 11 USPTO granted patents and 4 published patent applications. Top assignee: Amylin Pharmaceuticals, Inc.. Active years: 1998-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Poway, CA (US) (1998 - 2011)
- San Diego, CA (US) (2011)
Company Filing History:
Years Active: 1998-2011
Title: The Innovative Contributions of Orville G Kolterman
Introduction
Orville G Kolterman is a prominent inventor based in Poway, California. He has made significant contributions to the field of obesity treatment, holding a total of 11 patents. His work focuses on innovative methods and formulations that aim to alleviate obesity and its related health issues.
Latest Patents
Among his latest patents are methods for treating obesity, which involve the administration of a therapeutically effective amount of an amylin or an amylin agonist, either alone or in conjunction with another obesity relief agent. Additionally, he has developed lyophilized formulations of exendins and exendin agonist analogs, providing novel formulations that contain these important compounds.
Career Highlights
Orville Kolterman has had a distinguished career, primarily working with Amylin Pharmaceuticals, Inc. His innovative approaches to obesity treatment have positioned him as a key figure in the pharmaceutical industry. His extensive research and development efforts have contributed to advancements in therapeutic options for patients struggling with obesity.
Collaborations
Throughout his career, Kolterman has collaborated with notable colleagues, including Andrew A Young and Timothy J Rink. These partnerships have fostered a collaborative environment that enhances the development of effective obesity treatments.
Conclusion
Orville G Kolterman's contributions to the field of obesity treatment through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
